Newsroom
Link to: Client news
Client news
The latest news from Optimum clients
Follow a manual added link
Conference
Optimum’s 16th Annual Healthcare Investor Conference
Follow a manual added link
Weekly wrap-up
Read Optimum’s round-up for the low-down on client and industry news
Resolution Therapeutics Announces Upcoming Presentations at the American Association for the Study of Liver Disease (AASLD) The Liver Meeting® 2024
/in Client newsNeuraxpharm expands operations into the Middle East
/in Client newsAstronauTx appoints Jane Rhodes as Chief Executive Officer and Expands Executive Team
/in Client newsWeekly wrap-up: $100m Series B financing for a bivalent vaccine, to new clinical data from a cutting-edge antibody-drug conjugate…
/in InsightsHeidelberg Pharma Announces New Clinical Data on Lead ATAC Candidate HDP-101 to be Presented at International Myeloma Society Annual Meeting 2024
/in Client newsBiocomposites to showcase innovations in infection management at EBJIS 2024
/in Client newsVicebio Announces $100 Million Series B Financing and Initiation of Phase 1 Clinical Study of RSV/hMPV Bivalent Vaccine
/in Client newsWeekly round-up: From a vaccine protein manufacturing collaboration, to the appointment of an orthopaedic devices expert…
/in InsightsRenovos Biologics strengthens its Board’s US expertise with appointment of Lisa Ferrara
/in Client newsPoolbeg Pharma plc – Interim results for the six months to 30 June 2024
/in Client newsBiocomposites acquires remaining shares in manufacturers of SYNICEM™ and Subiton products
/in Client newsMinervaX and Wacker Biotech Announce Manufacturing Collaboration for Prophylactic Vaccine Targeting Group B Streptococcus
/in Client newsWeekly round-up: The appointment of a new CEO to Phase 1 data from a novel GLP-1 receptor agonist…
/in InsightsAlchemab appoints Co-Founder Jane Osbourn as Chief Executive Officer
/in Client newsQL Biopharm Presented Results from Phase 1c Clinical Study on its Novel Once-Monthly GLP-1RA ZT002 at EASD 2024
/in Client news